As a result, new targets for the development of novel therapeutics to halt this most damaging process in chronic kidney diseases (CKD) have been identified through a better knowledge of the various processes through which TGF-β1 modulates fibrosis. The gene discussed is TGFB1; the disease is chronic kidney disease.